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Background: Ileus is common after gastrointestinal surgery and has been identified as a research priority.
Several issues have limited previous research, including a widely accepted definition and agreed outcome
measure. This review is the first stage in the development of a core outcome set for the return of bowel
function after gastrointestinal surgery. It aims to characterize the extent of variation in current outcome
reporting.
Methods: A systematic search ofMEDLINE, Embase, CINAHL (Cumulative Index toNursing andAllied
Health Literature) and the Cochrane Library was performed for 1990–2017. RCTs of adults undergoing
gastrointestinal surgery, including at least one reported measure relating to return of bowel function,
were eligible. Trial registries were searched across the same period for ongoing and completed (but not
published) RCTs. Definitions of ileus and outcome measures describing the return of bowel function
were extracted.
Results: Of 5670 manuscripts screened, 215 (reporting 217 RCTs) were eligible. Most RCTs involved
patients undergoing colorectal surgery (161 of 217, 74⋅2 per cent). A total of 784 outcomes were identified
across all published RCTs, comprising 73 measures (clinical: 63, 86 per cent; radiological: 6, 8 per cent;
physiological: 4, 5 per cent). The most commonly reported outcome measure was ‘time to first passage of
flatus’ (140 of 217, 64⋅5 per cent). The outcomes ‘ileus’ and ‘prolonged ileus’ were defined infrequently
and variably.
Conclusion: Outcome reporting for the return of bowel function after gastrointestinal surgery is variable
and not fit for purpose. An agreed core outcome set will improve the consistency, reliability and clinical
value of future studies.
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Introduction
Ileus, defined as a delayed return of bowel function after
surgery, occurs in 10–20 per cent of patients under-
going elective gastrointestinal surgery, and may lead to
painful abdominal distension, vomiting, constipation and
distress1,2. As part of its research prioritization process, the
Association of Coloproctology of Great Britain and Ireland
identified ileus as a research priority, and called for further
research to identify clinically effective, patient-focused
management strategies3.
Over the past 20 years, numerous interventions to opti-
mize the return of bowel function have been tested in
RCTs4. Many were limited by methodological challenges
related to the assessment of complex interventions and
heterogeneity in the choice of outcome measures5. Poor
standardization and variation in the use of outcome mea-
sures is problematic for translation into clinical practice.
Although several groups have attempted to address this
problem through consensus statements, the impact of these
efforts remains unclear6,7.
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Studies identified for screening
n=5670
Titles and abstracts screened
n=4611
Full-text manuscripts reviewed
n=374
Provisional eligibility
n=215
Eligibility 215 manuscripts (217 RCTs)
Eligible/non-duplicated registry
entries n=96
Duplicates excluded n=1059
Irrelevant studies excluded n=4237
Excluded n=159
 Ileus/GI recovery not measured n=32
 Not published as full text n=31
 Published before 1 January 1990 n=29
 Not published in English n=27
 Wrong study design n=21
 Procedure not involving GI tract n=8
 Other n=11
Final eligibility
215 manuscripts (217 RCTs)
96 registry entries
Fig. 1 Flow diagram of included studies. GI, gastrointestinal
The COMET (Core Outcome Measures in Effective-
ness Trials) Initiative aims to develop agreed ‘core out-
come sets’, which represent the minimum information that
should be reported in all trials of a specific condition8.
No such outcomes set for the return of bowel function
after gastrointestinal surgery has been developed. Consis-
tent reporting would increase the value of RCTs, improve
the quality of meta-analyses and enhance decision-making
when integrating new treatments into clinical practice9.
This review represents the first stage in the development
process. It aimed to identify all reported outcomemeasures
for the return of bowel function used in RCTs of gastroin-
testinal surgery, as well as characterizing the extent of varia-
tion in order to develop an interim strategy for maximizing
the value of future studies.
Methods
Study design
This study was developed with the assistance of patient rep-
resentatives at a national stakeholder meeting in London,
UK in April 2017. A systematic review was performed
according to a predefined protocol. It was registered
prospectively on the PROSPERO database of systematic
reviews (CRD42017082351) and reported in line with the
PRISMA guidelines10.
Search
A search strategy was developed to identify outcome
measures used to assess the return of bowel function after
gastrointestinal surgery (Table S1, supporting informa-
tion). Two independent investigators performed searches
of MEDLINE (via OvidSP), Embase (via OvidSP),
CINAHL (Cumulative Index toNursing and AlliedHealth
Literature) (via EBSCOhost) and the Cochrane Library on
15 June 2017. Titles and abstracts were screened for eligi-
bility via Covidence Systematic Review Software (Veritas
Health Innovation, Melbourne, Australia; www.covidence
.org), followed by inspection of full-text manuscripts as
appropriate. Discrepancies between investigators were dis-
cussed with the review team until consensus was achieved.
All ‘primary registries’ included in the WHO Registry
Network (including ClinicalTrials.gov) were queried for
ongoing and completed (but unpublished) RCTs (Table S2,
supporting information). A simplified search strategy (ileus
AND surgery) was applied to these databases. Unique trial
identifiers and details of corresponding authors were
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Table 1 Characteristics of the included RCTs
No. of studies (n=217)
Year of publication
1990–1999 25 (11⋅5)
2000–2009 85 (39⋅2)
2010–2017 107 (49⋅3)
Type of surgery
Colorectal 161 (74⋅2)
Upper gastrointestinal 29 (13⋅4)
Mixed 27 (12⋅4)
Setting
Africa 2 (0⋅9)
Asia 82 (37⋅8)
Australasia 6 (2⋅8)
Europe 70 (32⋅3)
North America 44 (20⋅3)
South America 4 (1⋅8)
Cross-continental 9 (4⋅1)
No. of centres
1 173 (79⋅7)
≥2 44 (20⋅3)
No. of arms
2 186 (85⋅7)
3 26 (12⋅0)
≥4 5 (2⋅3)
Blinding
None 59 (27⋅2)
Single 44 (20⋅3)
Double 75 (34⋅6)
Unknown 39 (18⋅0)
Recruitment
<100 139 (64⋅1)
≥100 78 (35⋅9)
Intervention
Behavioural 3 (1⋅4)
Device 3 (1⋅4)
Dietary supplement 37 (17⋅1)
Drug 100 (46⋅1)
Procedure 64 (29⋅5)
Other 10 (4⋅6)
No. of bowel recovery outcomes
1–5 169 (77⋅9)
6–10 48 (22⋅1)
Bowel recovery as primary outcome
Yes 82 (37⋅8)
No 103 (47⋅5)
Unclear 32 (14⋅7)
Values in parentheses are percentages.
used to de-duplicate RCTs that were already identified as
published manuscripts.
Eligibility criteria
All RCTs including adult patients (18 years old or above)
undergoing gastrointestinal surgery were eligible for inclu-
sion. Eligible studies had to include at least one outcome
measure (primary or secondary) describing the return of
bowel function or the incidence of ileus. RCTs published
in a peer-reviewed journal (in print or online) or regis-
tered on a WHO-approved trials registry were included.
Non-randomized study designs, reports published in a
non-English language and grey literature were excluded.
Outcomes
The primary outcome was the number of outcome mea-
sures relating to the return of bowel function. Secondary
outcomes were the type of outcome (primary or secondary)
and mode of measurement (clinical, radiological or physio-
logical). If outcomes of ‘ileus’ were reported, the definition
assigned to ileus (or absence of) was documented.
Definitions
RCTs were defined as prospective studies with partici-
pants randomized to one of a minimum of two interven-
tion groups. Gastrointestinal surgery was defined as any
surgical procedure performed on the oesophagus, stom-
ach, small bowel, colon, rectum or anus. The primary out-
come of each RCTwas identified according to information
provided in the manuscript or trial registry entry, if avail-
able.Where ambiguity persisted, the primary outcome was
identified according to the study’s reported sample-size cal-
culation. Only outcomes describing the return of bowel
function were considered; adverse events (such as nau-
sea attributed directly to opioid consumption) and other
generic measures of recovery (such as duration of hospital
stay) were not considered. Outcome measures were clas-
sified as ‘clinical’ measures (those measured by clinicians
or reported by patients), ‘physiological’ (those measur-
ing physiological processes) and ‘radiological’ (those mea-
sured using either cross-sectional or non-cross-sectional
imaging). They were further classified according to core
areas described by the OMERACT (Outcome Measures
in Rheumatology) filter 2.0, including: Life Impact, Patho-
logical Manifestations and Resource Use11. The core area
of Death was not considered relevant in the present con-
text. Individual outcome measures could be classified into
one or multiple core areas.
Data extraction
A single investigator extracted data from eligible
manuscripts. Data fields of interest included manuscript
demographics (journal and year), procedure type and
study characteristics (setting, population, recruitment and
blinding). If data extraction was unclear, corresponding
authors were contacted for clarification. Study outcome
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Table 2 Reported outcomes in published RCTs
No. of reports
Reported outcome measure Total Colorectal* UGI
Mode of
outcome
Primary
outcome
Secondary
outcome
Unclear
outcome
Time to first passage of flatus 140 120 20 Clinical 19 (13⋅6) 98 (70⋅0) 23 (16⋅4)
Time to first passage of stool 69 62 7 Clinical 18 (26) 39 (57) 12 (17)
Time to first bowel movement 65 61 4 Clinical 16 (25) 41 (63) 8 (12)
Incidence of postoperative ileus 58 52 6 Clinical 4 (7) 44 (76) 10 (17)
Need for nasogastric tube/replacement 45 37 8 Clinical 2 (4) 36 (80) 7 (16)
Incidence and/or duration of vomiting 38 35 3 Clinical 1 (3) 30 (79) 7 (18)
Time to first fluid intake 28 25 3 Clinical 1 (4) 23 (82) 4 (14)
Time to first solid intake 26 21 5 Clinical 0 (0) 21 (81) 5 (19)
Incidence and/or duration of nausea 25 20 5 Clinical 0 (0) 21 (84) 4 (16)
Time to tolerate solid intake 23 23 0 Clinical 1 (4) 21 (91) 1 (4)
Time to tolerate normal/regular diet 22 21 1 Clinical 0 (0) 21 (95) 1 (5)
Time to detect bowel sounds 21 19 2 Clinical 0 (0) 14 (67) 7 (33)
Time to first oral intake 15 12 3 Clinical 0 (0) 10 (67) 5 (33)
GI-2 composite outcome 13 13 0 Clinical 3 (23) 10 (77) 0 (0)
Incidence of prolonged postoperative ileus 13 13 0 Clinical 2 (15) 11 (85) 0 (0)
Incidence and/or extent of abdominal
distension (generic scale)
13 11 2 Clinical 0 (0) 9 (69) 4 (31)
Time to return of bowel function 11 11 0 Clinical 0 (0) 10 (90) 1 (9)
Duration of nasogastric tube placement 11 5 6 Clinical 0 (0) 7 (64) 4 (36)
Duration of postoperative ileus 10 10 0 Clinical 1 (10) 7 (70) 2 (20)
GI-3 composite outcome 8 8 0 Clinical 6 (75) 2 (25) 0 (0)
Incidence and/or extent of abdominal pain
(generic scale)
8 7 1 Clinical 0 (0) 8 (100) 0 (0)
Gastrointestinal transit: number of remnant
opaque markers (radiograph)
7 6 1 Radiological 4 (57) 3 (43) 0 (0)
Proportion/amount of food intake per meal 7 5 2 Clinical 0 (0) 7 (100) 0 (0)
Time to first soft food 7 4 3 Clinical 0 (0) 7 (100) 0 (0)
Time to return of appetite 6 5 1 Clinical 0 (0) 3 (50) 3 (50)
Readiness for discharge based on
gastrointestinal function
6 6 0 Clinical 0 (0) 6 (100) 0 (0)
Time to tolerate fluid intake 5 5 0 Clinical 0 (0) 5 (100) 0 (0)
Time to tolerate oral intake 5 5 0 Clinical 1 (20) 3 (60) 1 (20)
Gastrointestinal motility: gastric/duodenal
pressure transducers (manometry)
5 1 4 Physiological 3 (60) 1 (20) 1 (20)
Need for parenteral nutrition 5 5 0 Clinical 0 (0) 5 (100) 0 (0)
Nutritional status: serum albumin 4 1 3 Clinical 0 (0) 4 (100) 0 (0)
Volume of nasogastric tube aspirate 3 2 1 Clinical 0 (0) 2 (67) 1 (33)
Need for antiemetic medication 3 2 1 Clinical 0 (0) 2 (67) 1 (33)
Gastrointestinal transit: number of evacuated
opaque markers (radiograph)
3 3 0 Radiological 2 (67) 1 (33) 0 (0)
Duration of parenteral nutrition 3 3 0 Clinical 0 (0) 3 (100) 0 (0)
Gastrointestinal transit: scintigraphy using
standard meal
3 3 0 Radiological 2 (67) 1 (33) 0 (0)
Time to intake of >1000 ml fluid per day 3 3 0 Clinical 0 (0) 2 (67) 1 (33)
Time to tolerate low-residue diet 2 2 0 Clinical 1 (50) 1 (50) 0 (0)
Incidence and/or duration of oral intolerance 2 2 0 Clinical 1 (50) 1 (50) 0 (0)
Gastrointestinal QoL (Gastrointestinal
Symptom Rating Scale)
2 0 2 Clinical 0 (0) 2 (100) 0 (0)
Gastrointestinal transit: ultrasonography using
standard meal
2 2 0 Radiological 0 (0) 1 (50) 1 (50)
Frequency of stool 2 1 1 Clinical 0 (0) 1 (50) 1 (50)
Time to first sips of water 2 1 1 Clinical 0 (0) 2 (100) 0 (0)
Need for laxative medication 2 2 0 Clinical 0 (0) 2 (100) 0 (0)
Incidence of readmission due to
postoperative ileus
2 2 0 Clinical 0 (0) 1 (50) 1 (50)
Gastrointestinal motility: intraoperative count
of bowel peristaltic waves over 1min
2 1 1 Clinical 2 (100) 0 (0) 0 (0)
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Table 2 Continued
No. of reports
Reported outcome measure Total Colorectal* UGI
Mode of
outcome
Primary
outcome
Secondary
outcome
Unclear
outcome
Gastric emptying: paracetamol
(acetaminophen) absorption
2 2 0 Physiological 1 (50) 0 (0) 1 (50)
Incidence and/or extent of upper abdominal
pain (Visick scale)
2 0 2 Clinical 0 (0) 0 (0) 2 (100)
Duration of prolonged postoperative ileus 1 1 0 Clinical 1 (100) 0 (0) 0 (0)
Abdominal circumference ratio 1 0 1 Clinical 0 (0) 1 (100) 0 (0)
Time to first stoma output 1 1 0 Clinical 0 (0) 0 (0) 1 (100)
Incidence of morbidity due to postoperative
ileus
1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Incidence of gastric upset 1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Incidence and/or extent of hunger (Visick
scale)
1 0 1 Clinical 0 (0) 0 (0) 1 (100)
Incidence of nasogastric tube aspirate
>500 ml per day
1 0 1 Clinical 0 (0) 1 (100) 0 (0)
Time to second passage of flatus 1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Cumulative frequency of flatus (within defined
time period)
1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Quantification of bowel gas (according to Gas
Volume Score)
1 0 1 Radiological 0 (0) 1 (100) 0 (0)
Time to first postoperative abdominal
peristalsis
1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Incidence of early postoperative ileus 1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Incidence of late postoperative ileus 1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Time to occurrence of postoperative ileus 1 0 1 Clinical 1 (100) 0 (0) 0 (0)
Frequency of bowel sounds 1 1 0 Clinical 0 (0) 0 (0) 1 (100)
Incidence and/or extent of upper abdominal
fullness (Visick scale)
1 0 1 Clinical 0 (0) 0 (0) 1 (100)
Vomiting after nasogastric tube removal 1 0 1 Clinical 0 (0) 1 (100) 0 (0)
Incidence of hiccups 1 1 0 Clinical 0 (0) 0 (0) 1 (100)
Incidence and/or duration of belching 1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Incidence and/or duration of regurgitation 1 0 1 Clinical 0 (0) 0 (0) 1 (100)
Incidence and/or duration of satiety 1 1 0 Clinical 0 (0) 1 (100) 0 (0)
Consistency of stool (Bristol Stool Chart) 1 0 1 Clinical 0 (0) 0 (0) 1 (100)
Gastrointestinal transit: scintigraphy
(HIDA) – bile transit through small bowel
1 0 1 Radiological 0 (0) 1 (100) 0 (0)
Gastrointestinal motility:
electrogastroenterography
1 1 0 Physiological 0 (0) 1 (100) 0 (0)
Gastric emptying: acetate breath test 1 1 0 Physiological 0 (0) 1 (100) 0 (0)
Values in parentheses are percentages. *Number of reports in colorectal studies (including studies of mixed colorectal and upper gastrointestinal tract
(UGI)). GI-2, composite outcome measure – time taken to pass first stool and tolerate oral intake; GI-3, composite outcome measure – time taken to
pass first stool or flatus and tolerate oral intake; QoL, quality of life; HIDA, hepatobiliary iminodiacetic acid.
measures were extracted verbatim and grouped to produce
frequencies. At this stage, small variations in reporting
(such as ‘time to pass stool’ and ‘time taken to pass stool’)
were rationalized.
Statistical analysis
Descriptive data are expressed using proportions and
median values. A subgroup analysis of outcome measures
for lower (colorectal) versus upper gastrointestinal surgery
was planned prospectively. All data were entered into
Microsoft Excel® (Microsoft, Redmond, Washington,
USA) for analysis.
Bias assessment
As this review reported a summary description of out-
come measures used in RCTs, rather than a measure of
clinical data, assessments of bias for each RCT were not
performed12,13.
Results
Study characteristics
A total of 5670 manuscripts were screened for eligibil-
ity, and 215 (reporting 217 RCTs) were included in the
review (Fig. 1; Table S3, supporting information). Most
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Table 3 Planned outcome measures in trial register entries
Reported outcome measure Mode of outcome No. of reports (n= 96)
Time to first passage of flatus Clinical 44 (46)
Time to first passage of stool Clinical 30 (31)
Incidence of postoperative ileus Clinical 28 (29)
Time to first bowel movement Clinical 18 (19)
Time to tolerate solid intake Clinical 16 (17)
GI-2 composite outcome Clinical 12 (13)
Incidence and/or duration of vomiting Clinical 12 (13)
Need for nasogastric tube/replacement Clinical 7 (7)
Incidence and/or duration of nausea Clinical 6 (6)
Time to return of bowel function Clinical 5 (5)
Time to detect bowel sounds Clinical 4 (4)
Incidence of prolonged postoperative ileus Clinical 4 (4)
GI-3 composite outcome Clinical 3 (3)
Time to tolerate normal/regular diet Clinical 3 (3)
Time to tolerate low-residue diet Clinical 3 (3)
Time to return of appetite Clinical 3 (3)
Duration of postoperative ileus Clinical 2 (2)
Incidence and/or extent of abdominal pain (generic scale) Clinical 2 (2)
Gastrointestinal transit: number of remnant SITZMARKS® markers (radiograph) Radiological 2 (2)
Volume of nasogastric tube aspirate Clinical 2 (2)
Time to tolerate fluid intake Clinical 2 (2)
Duration of prolonged postoperative ileus Clinical 2 (2)
Time to first solid intake Clinical 1 (1)
Time to first oral intake Clinical 1 (1)
Time to first fluid intake Clinical 1 (1)
Duration of nasogastric tube placement Clinical 1 (1)
Readiness for discharge based on gastrointestinal function Clinical 1 (1)
Time to tolerate oral intake Clinical 1 (1)
Gastrointestinal transit: number of evacuated SITZMARKS® markers (radiograph) Radiological 1 (1)
Incidence and/or duration of oral intolerance Clinical 1 (1)
Abdominal circumference ratio Clinical 1 (1)
Time to first stoma output Clinical 1 (1)
Incidence of morbidity due to postoperative ileus Clinical 1 (1)
Incidence of gastric upset Clinical 1 (1)
Gastrointestinal Quality of Life Index (GIQLI) score Clinical 1 (1)
Gastrointestinal motility: dynamic MRI Radiological 1 (1)
Values in parentheses are percentages. SITZMARKS® (Konsyl Pharmaceuticals, Easton, Maryland, USA). GI-2, composite outcome measure – time
taken to pass first stool and tolerate oral intake; GI-3, composite outcome measure – time taken to pass first stool or flatus and tolerate oral intake.
RCTs involved patients undergoing colorectal surgery
(161, 74⋅2 per cent), and the majority tested either a drug
(100, 46⋅1 per cent) or a procedural (64, 29⋅5 per cent)
intervention. Institutions in Asia (82 of 217, 37⋅8 per cent),
Europe (70 of 217, 32⋅3 per cent) andNorth America (44 of
217, 20⋅3 per cent) were the most frequent study locations.
Themajority of RCTs were single-centre studies (173, 79⋅7
per cent) reporting on small populations (fewer than 100
participants) (139, 64⋅1 per cent). The median number of
outcomes relating to the return of bowel function was 3
(i.q.r. 2–5), and 82 RCTs (37⋅8 per cent) included one of
these as a primary study outcome. Full study characteristics
are shown in Table 1.
Published outcome measures
Across all RCTs, a total of 784 outcomes relating to the
return of bowel function were reported. These comprised
73 discrete outcome measures (Table 2). Approximately
one-third (25 of 73, 34 per cent) of identified outcomemea-
sures were reported only once without replication. Overall,
the most frequently reported measures were ‘time to first
passage of flatus’ (140 of 217, 64⋅5 per cent), ‘time to first
passage of stool’ (69 of 217, 31⋅8 per cent) and ‘time to first
bowel movement’ (65 of 217, 30⋅0 per cent). This differed
slightly for the subset of RCTs involving upper gastro-
intestinal surgery, where the most common outcome
measures were ‘time to first passage of flatus’ (20 of 29, 69
per cent), ‘need for nasogastric tube insertion/reinsertion’
(8 of 29, 28 per cent) and ‘time to first passage of stool’ (7
of 29, 24 per cent).
Planned outcome measures
Some 96 eligible registry entries were identified (Fig. 1).
Assessment of these entries identified 224 planned
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Incidence of postoperative ileus
GI-2 composite outcome
Time to tolerate normal/regular diet
Gastrointestinal Symptom Rating Scale
Time to return of bowel function
Incidence and/or duration of satiety
Time of return of appetite
Time to tolerate low-residue diet
Time to second passage of flatus
Time to tolerate oral intake
Time to first solid intake
Time to tolerate solid intake
Frequency of stool
Incidence of gastric upset
Incidence and/or extent of hunger (Visick scale)
Time to first soft food
Incidence and/or duration of belching
Time to intake of > 1000 ml fluids per day
Incidence of hiccups
Time to first bowel movement
Time to first sips of water
Incidence and/or duration of regurgitation
Time to first stoma output
Time to first oral intake
Proportion/amount of food intake per meal
Time to first fluid intake
Time to first passage of flatus
Time to tolerate fluid intake
Time to first passage of stool
Incidence of prolonged postoperative ileus
Incidence and/or extent of abdominal pain (generic scale)
Vomiting after nasogastric tube removal
Incidence of late postoperative ileus
Incidence and/or extent of upper abdominal pain (Visick scale)
Incidence and/or extent of abdominal distension (generic scale)
Duration of postoperative ileus
Consistency of stool (Bristol Stool Chart)
Incidence and/or extent of upper abdominal fullness (Visick scale)
Time to occurrence of postoperative ileus
Duration of prolonged postoperative ileus
Incidence and/or duration of oral intolerance
Need for laxative medication
Need for antiemetic medication
Incidence of early postoperative ileus
Duration of parenteral nutrition
Need for parenteral nutrition
GI-3 composite outcome
Duration of nasogastric tube placement
Incidence and/or duration of nausea
Incidence and/or duration of vomiting
Gastrointestinal transit: scintigraphy (HIDA) – bile transit through small bowel
Quantification of bowel gas (according to Gas Volume Score) (radiograph)
Gastrointestinal transit: ultrasonography using standard meal
Gastrointestinal transit: scintigraphy using standard meal
Abdominal circumferential ratio
Incidence of readmission due to postoperative ileus
Readiness for discharge based on gastrointestinal function
Incidence of nasogastric tube aspirate > 500 ml per day
Volume of nasogastric tube aspirate
Cumulative frequency of flatus (within defined time period)
Time to detect bowel sounds
Need for nasogastric tube/replacement
Time to first postoperative abdominal peristalsis
Nutritional status: serum albumin
Incidence of morbidity due to postoperative ileus
Gastrointestinal motility: intra-operative count of bowel peristaltic waves over 1 minute
Frequency of bowel sounds
Gastrointestinal motility: gastric/duodenal pressure transducers (manometry)
Gastrointestinal motility: electrogastroenterography
Gastric emptying: acetate breath test
Gastric emptying: acetaminophen absorption
Gastrointestinal transit: number of remnant opaque markers (radiograph)
Gastrointestinal transit: number of evacuated opaque markers (radiograph)
Radiology
Life impact and pathological
manifestation
Life impact
Life impact and resource use
Physiological
Pathological manifestation
Clinical
Fig. 2 Map of 73 identified outcome measures according to core areas. GI-2, composite outcome measure – time taken to pass first stool
and tolerate oral intake; GI-3, composite outcome measure – time taken to pass first stool or flatus and tolerate oral intake
outcomes, comprising 36 discrete outcome measures
relating to the return of bowel function (Table 3). The
median number per trial was 2 (i.q.r. 1–3). The most
commonly planned outcome measures were similar to
those in published manuscripts, including ‘time to first
passage of flatus’ (44 of 96, 46 per cent), ‘time to first
passage of stool’ (30 of 96, 31 per cent) and ‘incidence of
postoperative ileus’ (28 of 96, 29 per cent). Two unique
outcome measures were identified, including ‘Gastroin-
testinal Quality of Life Index (GIQLI) score’ (1 of 96, 1
per cent) and ‘Gastrointestinal motility: dynamic MRI’
(1 of 96, 1 per cent). These were not replicated elsewhere.
Classification of outcome measures
Across published and plannedRCTs, clinical outcomemea-
sures (including clinical scales, instruments and consulta-
tions) were largely favoured: 63 of 73 (86 per cent) and
33 of 36 (92 per cent) respectively (Fig. 2). Radiological
modalities comprised six of 73 (8 per cent) published mea-
sures and three of 36 (8 per cent) planned measures in
trial registries. These included radiographic, nuclear and
MRI assessments of gastrointestinal transit. Physiological
measures were infrequent (4 of 73 (5 per cent) and 0 of 36
(0 per cent) respectively), and included measures of gas-
tric emptying such as acetate breath-testing, paracetamol
(acetaminophen) absorption and gastric manometry. The
vast majority of outcome measures were relevant to Life
Impact and PathologicalManifestation core areas, with few
concerned with Resource Use.
Definitions of ileus
The outcome measures postoperative ileus and prolonged
postoperative ileus were defined in 17 of 58 reports (29 per
cent) and their duration was described in five of 13 reports
(38 per cent). All reported definitions demonstrated con-
siderable variability (Table 4). Most incorporated elements
of both upper and lower gastrointestinal function (7 of 17
(41 per cent) and 4 of 5 (80 per cent) respectively), fol-
lowed by elements of lower gastrointestinal function alone
(6 of 17 (35 per cent) and 1 of 5 (20 per cent)). The major-
ity of definitions defined postoperative ileus or prolonged
postoperative ileus according to incidence (12 of 17 (71
per cent) and 4 of 5 (80 per cent)), whereas the remain-
der defined them according to the time taken to resolve (5
of 17 (29 per cent) and 1 of 5 (20 per cent)).
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Table 4 Definitions of ileus as reported in published literature
Definition: incidence/duration of ‘postoperative ileus’ (n=17 of 58, 29 per cent)
‘delay of the first postoperative flatus lasting for >72hours (3⋅0days) after surgery… or some other status requiring intervention for treatment for
ileus’
‘Patients meeting 2 or more of the following 5 criteria on or after day 4 postoperatively – nausea OR vomiting over the preceding 12 hours; inability
to tolerate a solid or semi-solid oral diet over the preceding 2 meal times; abdominal distension; absence of flatus AND stool over the preceding
24 hours; and radiologic evidence of ileus on abdominal plain film or CT over the preceding 24 hours’
‘defined as lack of passage of flatus or stool and intolerance to oral intake for at least 24 h… on day 5 after operation’
‘intolerance to oral food in the absence of clinical and radiological data of mechanical obstruction for more than 72 hours, or the need for a
nasogastric tube’
‘Ileus persisted until patient had normal bowel sounds or he/she was passing flatus’
‘defined as failure of bowel sounds to return within 12 h postoperatively’
‘the number of days before signs of restoration of the bowel function appeared (bowel movement, flatus, and stool) after which oral intake was
restarted’
‘resolution defined as passage of flatus or stool in the absence of nausea, vomiting, or abdominal distention’
‘need for nasogastric tube reinsertion or discontinuation of oral intake’
‘Adynamic or paralytic ileus that persisted for >3days following surgery’
‘the condition in which the time required for the resumption of flatus passage after surgery exceeded 48hours’
‘The resolution of postoperative ileus was defined as having a bowel movement in the absence of abdominal distention and vomiting’
‘the interval between the end of surgery and the first passage of gas or stool through the anus’
‘defined as postoperative nausea/vomiting, accompanied by abdominal distention, absence of bowel function, and x-ray findings consistent with
ileus’
‘non-passage of gas or solid per rectum for 5 days, cessation of such passage, vomiting (on day 1), nasogastric intubation, continued intravenous
fluids’
‘abdominal distension, no flatus or bowel movement, or nausea/vomiting that prevents oral intake or requires therapeutic use of nasogastric tube’
‘the inability to tolerate and resume oral solid diet intake beyond 6days after surgery’
Definition: incidence/duration of ‘prolonged postoperative ileus’ (n=5 of 13, 38 per cent)
‘The presence of two or more of the following signs/symptoms over the 4th postoperative day: abdominal distension, persistent and nonspecific
abdominal pain, vomits and/or nausea, the absence of passage of flatus or stools, oral intolerance, and radiological findings on plain radiology’
‘Defined as being resolved when all 4 of the following criteria were met – absence of nausea AND vomiting for 12 hours with nasogastric tube
spigotted or removed; ability to tolerate a solid or semi-solid diet at the preceding mealtime; absence of abdominal distension; and passage of
flatus OR stool over the preceding 24 hours’
‘no passage of flatus or stool by the end of the fifth post-operative day’
‘the inability to tolerate diet 5 days after surgery in the absence of active bowel sounds with the need for nasogastric decompression’
‘Two or more of the following criteria: (i) nausea/vomiting, (ii) inability to tolerate an oral diet for >24h, (iii) absence of flatus for >24h, (iv) distension
and (v) radiological confirmation occurring on or after day 4 postoperatively without prior resolution of POI’
Discussion
This review identified multiple outcome measures describ-
ing the return of bowel function after gastrointestinal
surgery. There was consistency in reporting of a small
number of terms, such as ‘time to first passage of fla-
tus’ and ‘time to first passage of stool’, but one-third
of all measures were used only once without replication.
The return of bowel function was often reported using
multiple outcomes, which may have led to inconsistent
results and unclear conclusions. When ileus was reported
as an outcome, a corresponding definition was frequently
not given; when this was provided, definitions varied
considerably.
Previous research on ileus has been limited by sev-
eral methodological challenges, including the lack of an
agreed definition5, such as the wide variation in definitions
for prolonged ileus in studies of colorectal surgery14.
Several attempts have been made to overcome these
difficulties through consensus agreements. A systematic
review and global survey6 proposed a series of definitions
for postoperative ileus, prolonged postoperative ileus
and recurrent ileus to delineate broad patterns of bowel
dysfunction. An international Delphi process7 found con-
sensus on the importance of abdominal pain, distension
and bowel sounds for identifying ileus in clinical practice.
The role of bowel sounds was later discredited as a reliable
measure15. Other efforts have included scoring tools to
measure the clinical impact of delayed return of bowel
function16. Some groups attempted to validate composite
outcome measures such as the composite measure GI-2
(defined as time to tolerance of oral diet and passage
of stool) with good results (area under the curve 0⋅9)17.
Currently, this offers the most representative assess-
ment of return of gastrointestinal function after surgery,
whereas the validity of other commonly used outcome
measures remains unclear. Clinicians are increasingly
recognizing the return of bowel function as a continuous
spectrum, rather than a dichotomous outcome, rang-
ing from transient nausea and vomiting to severe bowel
dysmotility18.
© 2018 The Authors. www.bjsopen.com BJS Open 2019; 3: 1–10
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Measuring the return of bowel function is important for
clinicians and those responsible for planning and commis-
sioning surgical services. For surgeons, it is important as
a means of reducing postoperative complications. Previous
research19 has suggested that early identification of delayed
bowel function (followed by targeted interventions such
as nasogastric decompression) may decrease the incidence
of pulmonary complications. In the absence of consistent
outcome measures, undertaking reliable meta-analysis will
remain difficult or simply impossible. For those involved in
the organization of surgical services, it is important to have
reliable evaluations of new treatments in order to plan the
provision of efficient clinical services. Agreement on a core
outcome set may offer an effective solution.
Based on this review, researchers should rationalize the
number of outcome measures relating to the return of
bowel function until an agreed core outcome set exists.
To avoid multiple, conflicting results across different mea-
sures, a clear primary outcome should be declared, with
a corresponding definition. This should be registered on
an approved trial registry to maximize transparency and
reduce reporting bias. In the meantime, researchers should
consider using the composite outcome measure GI-2 (time
to tolerance of oral diet and passage of stool) as a validated,
evidence-based measure that reflects the return of both
upper and lower gastrointestinal function. Researchers
should also consider the routine collection of quality of
life data.
Previous studies have focused on broad definitions of
ileus in the setting of colorectal surgery; this may not
reveal the full extent of the issue. Return of gastrointesti-
nal function is a challenge in many fields of abdominal
(and non-abdominal) surgery. As the focus of this review
is on clinical manifestations (rather than pathophysiolog-
ical mechanisms), cautious extrapolation of these results
across these other surgical areas might still be reasonable.
This review was unable to distinguish between measures of
ileus and postoperative nausea and vomiting. While these
may well represent different aetiological entities, their
clinical manifestations share similarities and a pragmatic
(patient-focused) perspective of gastrointestinal function is
encouraged. As this review focused on RCTs of gastroin-
testinal surgery, and excluded studies with an observational
design, the benefits of prospective design have to be bal-
anced against the extent of generalizability of the results to
an unselected population.
The reporting of postoperative bowel function is lim-
ited by unacceptable variation in outcome measures and a
paucity of evidence to describe their validity. This undoubt-
edly contributes to the challenges encountered in iden-
tifying and evaluating the return of bowel function after
gastrointestinal surgery. An agreed core outcome set is
required.
Acknowledgements
The authors are grateful to all attendees of the Gastroin-
testinal Recovery Research Day (28 April 2017 at the Royal
College of Surgeons of England, London, UK), supported
by the Association of Coloproctology of Great Britain and
IrelandDelphi research programme and the Bowel Disease
Research Foundation.
Disclosure: The authors declare no conflict of interest.
References
1 Scarborough JE, Schumacher J, Kent KC, Heise CP,
Greenberg CC. Associations of specific postoperative
complications with outcomes after elective colon resection: a
procedure-targeted approach toward surgical quality
improvement. JAMA Surg 2017; 152: e164681.
2 Hughes M, Coolsen MM, Aahlin EK, Harrison EM,
McNally SJ, Dejong CH et al. Attitudes of patients and care
providers to enhanced recovery after surgery programs after
major abdominal surgery. J Surg Res 2015; 193: 102–110.
3 Tiernan J, Cook A, Geh I, George B, Magill L, Northover J
et al. Use of a modified Delphi approach to develop research
priorities for the Association of Coloproctology of Great
Britain and Ireland. Colorectal Dis 2014; 16: 965–970.
4 Chapman SJ, Pericleous A, Downey C, Jayne DG.
Postoperative ileus following major colorectal surgery. Br
J Surg 2018; 105: 797–810.
5 Chapman SJ, Wells CI. Challenges in ileus research.
Colorectal Dis 2018; 20: 639.
6 Vather R, Trivedi S, Bissett I. Defining postoperative ileus:
results of a systematic review and global survey. J Gastrointest
Surg 2013; 17: 962–972.
7 Gero D, Gié O, Hübner M, Demartines N, Hahnloser D.
Postoperative ileus: in search of an international consensus
on definition, diagnosis, and treatment. Langenbecks Arch
Surg 2017; 402: 149–158.
8 Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby
JM, Brookes ST et al. The COMET Handbook: version 1.0.
Trials 2017; 18(Suppl 3): 280.
9 Kirkham JJ, Gargon E, Clarke M, Williamson PR. Can a
core outcome set improve the quality of systematic
reviews? – a survey of the Co-ordinating Editors of
Cochrane Review Groups. Trials 2013; 14: 21.
10 Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC,
Ioannidis JP et al. The PRISMA statement for reporting
systematic reviews and meta-analyses of studies that evaluate
healthcare interventions: explanation and elaboration. BMJ
2009; 339: b2700.
11 Boers M, Kirwan JR, Wells G, Beaton D, Gossec L,
d’Agostino MA et al. Developing core outcome measurement
© 2018 The Authors. www.bjsopen.com BJS Open 2019; 3: 1–10
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
10 S. J. Chapman, G. Thorpe, A. E. Vallance, D. P. Harji, M. J. Lee and N. S. Fearnhead
sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol
2014; 67: 745–753.
12 van ’t Hooft J, Duffy JM, Daly M, Williamson PR, Meher S,
Thom E et al.; Global Obstetrics Network (GONet). A core
outcome set for evaluation of interventions to prevent
preterm birth. Obstet Gynecol 2016; 127: 49–58.
13 Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N,
McNair AGK et al.; ENiGMA collaborators. Developing a
core outcome set for fistulising perianal Crohn’s disease. Gut
2018. [Epub ahead of print].
14 Wolthuis AM, Bislenghi G, Fieuws S, de Buck van
Overstraeten A, Boeckxstaens G, D’Hoore A. Incidence of
prolonged postoperative ileus after colorectal surgery: a
systematic review and meta-analysis. Colorectal Dis 2016; 18:
O1–O9.
15 Read TE, Brozovich M, Andujar JE, Ricciardi R, Caushaj
PF. Bowel sounds are not associated with flatus, bowel
movement, or tolerance of oral intake in patients after major
abdominal surgery. Dis Colon Rectum 2017; 60: 608–613.
16 Venara A, Slim K, Regimbeau JM, Ortega-Deballon P,
Vielle B, Lermite E et al. Proposal of a new classification of
postoperative ileus based on its clinical impact-results of a
global survey and preliminary evaluation in colorectal
surgery. Int J Colorectal Dis 2017; 32: 797–803.
17 van Bree SH, Bemelman WA, Hollmann MW, Zwinderman
AH, Matteoli G, El Temna S et al. Identification of clinical
outcome measures for recovery of gastrointestinal motility in
postoperative ileus. Ann Surg 2014; 259: 708–714.
18 Hedrick TL, McEvoy MD, Mythen MMG, Bergamaschi R,
Gupta R, Holubar SD et al.; Perioperative Quality Initiative
(POQI) 2 Workgroup. American Society for Enhanced
Recovery and Perioperative Quality initiative joint consensus
statement on postoperative gastrointestinal dysfunction
within an enhanced recovery pathway for elective colorectal
surgery. Anesth Analg 2018; 126: 1896–1907.
19 Yorkshire Surgical Research Collaborative. Multicentre
observational study of gastrointestinal recovery after elective
colorectal surgery. Colorectal Dis 2018; 20: 536–544.
Supporting information
Additional supporting information can be found online in the Supporting Information section at the end of the
article.
© 2018 The Authors. www.bjsopen.com BJS Open 2019; 3: 1–10
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
